Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eppikajutsuto for lymphatic malformations
jRCTs041210007Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of etsuhijika-jutsuto in lymphangioma, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Tumor volume response at 6 months. Started Aug 2021; status: completed.
02
Drugs
etsuhijika-jutsuto
03
Conditions
lymphangioma
Beyond the preview
Go deeper on jRCTs041210007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210007.